Are functional constipation and constipation-subtype irritable bowel syndrome distinct with respect to 5-hydroxytryptamine signalling and motor-sensory function?. (13th March 2011)

• Record Type: Journal Article
• Authors: Shekhar, C; Monaghan, P; Adaway, J; Morris, J; Whorwell, P; Keevil, B; Houghton, L A
• Is Part Of: Gut. Volume 60:(2011)Supplement 1
• Page Start: A163
• Page End: A164
• Publication Date: 2011-03-13
• Subjects: 5 HT -- Constipation -- Functional Gastrointestinal Disorders (FGID) -- IBS -- Rectal Sensitivity -- ROME III; Gastroenterology -- Periodicals; 616.33
• DOI: 10.1136/gut.2011.239301.346
• Languages: English
• ISSNs: 0017-5749

Abstract

Abstract : Introduction: Recent studies suggest that patients identified by Rome III criteria for functional constipation (FC) and irritable bowel syndrome with constipation (IBS-C) are not distinct groups. We have shown that patients with IBS-C exhibit limited 5-HT response to meal ingestion, with plasma concentrations remaining similar to fasting. Our aim was to determine whether patients with FC show a similar 5-HT meal response as IBS-C, and to investigate relationships to motor-sensory function. Methods: 23 IBS-C patients (aged 19–50 years; Rome III), 11 FC patients (25–46 years; Rome III) and 23 healthy volunteers (HV) (20–49 years) were recruited. Plasma 5-HT concentrations were measured under fasting (2 h) and fed (4 h) conditions. Within 2 weeks, oro-caecal (hydrogen breath) and colonic (radio-opaque markers followed by X-ray) transit, along with rectal sensitivity (barostat) were determined. Results: FC and IBS-C had similarly reduced 5-HT responses to meal ingestion (mean increase from fasting (SD), FC: −1.1 nmol/l (±6.9), p=0.1; IBS-C: −1.9 nmol/l (±7.0), p=0.02) compared with HV (+ 4.7 nmol/l (±9.6)), but comparable fasting 5-HT concentrations (FC: 34.2 nmol/l (±13.2); IBS-C: 27.8 nmol/l (±17.3); HV: 27.0 nmol/l (±9.6)). Likewise, FC and IBS-C have reduced colonic (FC: 61.6 h (±17.9), p=0.001; IBS-C: 55.6 h (±18.5), p=0.001 vs HV: 34.6 h (±17.8)) but not orocecal ((FC: 321.4 min (±96.6); IBS-C: 311.7 min (±96.6) vs HV: 301.8 min (±87.5)) transit compared with HV. Only rectal sensitivity differed, with IBS-C exhibiting lower pain thresholds (23.4 mm Hg (±8.3), p=0.03) but not FC (32.7 mm Hg (±12.2) compared with HV (30.7 mm Hg (±8.2)). Moreover, although the 5-HT meal response was similar between hyper- (−0.7 nmol/l (±4.9)), normo- (−1.5 nmol/l (±7.5) and hypo- (−4.7 nmol/l (±7.8)) sensitive constipated patients, those with hypo-sensitivity (FC (27%) and IBS-C (4%)) had higher fasting and fed 5-HT concentrations (fasting: 44.3 nmol/l (±17.2), fed: 39.6 nmol/l (±20.8), p=0.001 and p=0.08, respectively) compared with HV (24.7 nmol/l (±7.5), 27.9 nmol/l (±9.5)). Hyper- (20.4 nmol/l (±7.6), 19.7 nmol/l (±5.6)) and normo- (30.7 nmol/l (±16.6), 29.2 nmol/l (±16.8)) sensitive patients were no different from HV. Conclusion: There appears to be no distinction between FC and IBS-C patients with respect to 5-HT meal response and GI transit, although IBS-C patients are more viscerally sensitivity. Hypo-sensitive constipated patients appear to have a distinct 5-HT profile.